Sue Sutter's Avatar

Sue Sutter

@pinksheetsutter

Senior Editor, Citeline's Pink Sheet, covering US FDA drug and biologic regulation and approvals. Views are my own.

216
Followers
107
Following
52
Posts
02.10.2023
Joined
Posts Following

Latest posts by Sue Sutter @pinksheetsutter

Preview
US FDA Memos Reveal Reasons For COVID Vaccine Policy Shift For Children And Pregnant Women FDA Principal Deputy Commissioner Sara Brenner and Tracy Beth HΓΈeg, then special assistant to the commissioner, wrote the scientific analyses underlying HHS' May 2025 decision to eliminate the recomme...

Who wrote the memos that led to CDC schedule changes for COVID vaccines last May? Why NIH and FDA political appointees of course. Nice find from @pinksheetsutter.bsky.social in court docs over ongoing AAP litigation over various Trump-era vaccine policy. First time these docs are public.

04.03.2026 21:55 πŸ‘ 4 πŸ” 3 πŸ’¬ 1 πŸ“Œ 0

Thanks for the plug, Sarah!

04.03.2026 22:25 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

CDC ACIP meeting announcement for March 18-19 - agenda items include discussions on COVID-19 vaccine injuries and Long-COVID. Recommendation votes may be scheduled for COVID-19 vaccine injuries and Long-COVID and ACIP recommendation methodology.

25.02.2026 14:03 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Actually, the Washington Post Layoffs Were a Bigger Bloodbath Than You Thought - Washingtonian The layoffs announced last week at the Washington Post were disfiguring to the esteemed news organization, with whole sections and departmentsβ€”sports, books, staff photographyβ€”wiped away, and devastat...

When you count the non-Guild represented people the Post laid off last week, it's close to half the newsroom,
@farhip.bsky.social writes:

09.02.2026 18:39 πŸ‘ 31 πŸ” 21 πŸ’¬ 1 πŸ“Œ 3

What US government body meets on Dec. 29 in the absence of a public health emergency like a pandemic? Why, it's the Advisory Commission on Childhood Vaccines, of course. public-inspection.federalregister.gov/2025-22982.p...

15.12.2025 13:59 πŸ‘ 3 πŸ” 1 πŸ’¬ 1 πŸ“Œ 0

As with the last few ACIP meetings, committee can't quite get its act together to vote.

04.12.2025 18:13 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
FDA Office of New Drugs Director Mary Thanh Hai Not Interested In CDER Director Job The 27-year agency veteran has not been formally approached about filling the vacancy created by George Tidmarsh’s resignation, but also is not interested in the position, the Pink Sheet has learned.

SCOOP: FDA Office of New Drugs director not approached about CDER's top post, but also not interested insights.citeline.com/pink-sheet/a...

07.11.2025 02:22 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

Another senior staff loss at US FDA - Dionna Green, former director of the Office of Pediatric Therapeutics, joins Canal Row Advisors

24.10.2025 15:47 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

$GSK Blenrep is back! @US_FDA approves belantamab, in combo w/ bortezomib and dexamethasone, for treatment of adults with r/r multiple myeloma who have received at least 2 prior lines of therapy. Approval follows negative adcomm in July and a user fee date extension

23.10.2025 20:05 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

@fda.gov grants accelerated approval to Stealth Biotherapeutics' elamipretide, the first treatment for Barth syndrome

19.09.2025 21:03 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image Post image Post image

The COVID-19 workgroup finally put their recommendations - the ones that ACIP will vote on - up.

The operative part - what's in ACIP'sΒ power - is that anyone can only get the vaccine under shared clinical decision making, and they essentially recommendΒ againstΒ it for most people under 65.Β 1/2

19.09.2025 18:17 πŸ‘ 57 πŸ” 27 πŸ’¬ 9 πŸ“Œ 2

Infants may receive a dose of hepatitis B vaccine before one month according to individual based decision-making.

18.09.2025 12:07 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

VOTE: The pediatric vaccine schedule should be updated to reflect the following change:
If a mother tests HBsAG-negative: The first dose of the Hepatitis B vaccine is not given until the child is at least one month old.

18.09.2025 12:06 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

For hepatitis B vaccine:

VOTE: All pregnant women should be tested for hepatitis B infection.

18.09.2025 12:06 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

@CDC #ACIP anticipated votes today.

For measles, mumps, rubella and varicella vaccines given before age 4 yrs, combined MMRV vaccine is not recommended.
Children in this age group should receive separate MMR and V vaccines

18.09.2025 12:05 πŸ‘ 1 πŸ” 1 πŸ’¬ 1 πŸ“Œ 0
Preview
Why Peter Marks Was Asked to Leave the FDA On Friday, Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for Biologics Evaluation and Research) citing differences with Health

new CDER head so familiar with FDA he blamed Peter Marks for Aduhelm... (Marks was head of CBER and Aduhelm was approved by CDER)
www.realclearpolicy.com/2025/04/01/w...

22.07.2025 00:23 πŸ‘ 5 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Oh, this is gonna be a fun one, today.

22.05.2025 13:17 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

"I am very concerned," Makary writes. "Historically, there has been a delayed recognition of fast-growing trends, such as opioid abuse and vaping addiction in youth. Let’s be proactive in understanding and addressing the use of tianeptine products."

08.05.2025 19:21 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

FDA Commissioner Martin Makary "Dear Colleagues" letter warns about rising number of AEs involving products containing tianeptine, aka "gas station heroin"

08.05.2025 19:21 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 1

US FDA announces 3 days of adcomms: May 20-21 #ODAC on four drugs; May 22 #VRBPAC on COVID vaccine formulation for 2025-2026

07.05.2025 12:57 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

the thing that is being watched closely now is not just how much RFK inserts himself into FDA decisions but how much Makary and his commissioner's office inserts himself into certain decisions the commissioner's office also has traditionally stayed out of.

29.04.2025 14:49 πŸ‘ 7 πŸ” 2 πŸ’¬ 1 πŸ“Œ 0
Preview
US FDA Miss On Stealth’s Elamipretide Boosts Signal Of Broader Delays Due To Staff Cuts Failing to meet the 29 April user fee date for the Barth syndrome treatment, and CDER’s request for a delay in responding to Vanda’s appeal of a tradipitant complete response letter, suggest a slowdow...

insights.citeline.com/pink-sheet/p...

29.04.2025 11:30 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
The FDA’s Crisis Is Everyone’s Crisis This Viewpoint discusses the Trump administration’s firings of thousands of US Food and Drug Administration employees and the ramifications of those actions on the agency’s congressionally given publi...

Out today in @jama.com, me and @nathancortez.bsky.social examine how the drastic staffing cuts at FDA run counter to FDA's many statutory obligations and the bargains embodied in user fee provisions - and put public health, innovation, and all of us at risk.

jamanetwork.com/journals/jam...

28.04.2025 19:34 πŸ‘ 59 πŸ” 31 πŸ’¬ 3 πŸ“Œ 3

Instead, FDA employees were encouraged to share with their children online information about the agency's work

24.04.2025 14:58 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 1

I'm told there are no US FDA-hosted activities for Bring Your Child To Work Day this year, marking a change from past years

24.04.2025 14:56 πŸ‘ 0 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

Fun fact from #ACIP meeting - Each measles case can cost $30,000 to $50,000 in public health response work. There were 712 reported cases in US as of April 10. I'll let you do the math.

15.04.2025 21:23 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

FDA, NIH Rare Disease Day, which was postponed in late February, now officially cancelled
"due to ongoing logistical and timing challenges"

15.04.2025 17:46 πŸ‘ 0 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

Must-read take from John Coster on how states might try to limit drug costs in Medicaid, including closed formularies, if Congress succeeds in cutting hundreds of billions of dollars from the program. "You can't cut all this money and then tie states' hands and say, 'Well, you can't do that.'" (1/2)

12.03.2025 17:44 πŸ‘ 8 πŸ” 5 πŸ’¬ 1 πŸ“Œ 0
Preview
CBER Losing Cell, Gene Therapy Leadership As Workforce Culling Continues Among those now leaving the US FDA’s biologics center is Lola Fashoyin-Aje, who was considered a rising star at the agency when she became director of the Office of Therapeutic Products’ Office of Cli...

Pink Sheet SCOOP: Lola Fashoyin-Aje among several staffers in FDA's cell/gene therapy office leaving the agency. My colleague Derrick Gingery with the story insights.citeline.com/pink-sheet/a...

12.03.2025 18:28 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

One of the 5 things HHS officials aren't doing is appearing at HIMMS.
STAT's @brittanytrang.bsky.social: "I ran into a group of conference attendees who were gathering confusedly outside a room where Medicare officials were supposed to be speaking. This is what the room looked like instead:"

05.03.2025 14:26 πŸ‘ 8 πŸ” 9 πŸ’¬ 0 πŸ“Œ 1